DEXCOM, INC. Segment Expenditure Addition To Long Lived Assets
DEXCOM, INC. (DXCM) reported Segment Expenditure Addition To Long Lived Assets of $84.70 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Notes › Segment Reporting
us-gaap:SegmentExpenditureAdditionToLongLivedAssets · last filed 2026-07-30
- DEXCOM, INC. segment expenditure addition to long lived assets for the quarter ending 2026-06-30 was $84.70M, a 9.99% decline year-over-year.
- DEXCOM, INC. segment expenditure addition to long lived assets for the quarter ending 2026-03-31 was $76.60M, a 11.95% decline year-over-year.
- DEXCOM, INC. segment expenditure addition to long lived assets for the quarter ending 2025-12-31 was $101.90M, a 18.22% decline year-over-year.
- DEXCOM, INC. segment expenditure addition to long lived assets for the quarter ending 2025-09-30 was $80.50M, a 27.61% decline year-over-year.
- DEXCOM, INC. segment expenditure addition to long lived assets for fiscal 2025 was $363.50M, a 1.31% increase from fiscal 2024.
- DEXCOM, INC. segment expenditure addition to long lived assets for fiscal 2024 was $358.80M, a 51.65% increase from fiscal 2023.
- DEXCOM, INC. segment expenditure addition to long lived assets for fiscal 2023 was $236.60M, a 35.14% decline from fiscal 2022.
- DEXCOM, INC. segment expenditure addition to long lived assets for fiscal 2022 was $364.80M.
| Period end | Segment Expenditure Addition To Long Lived Assets 3 month | Segment Expenditure Addition To Long Lived Assets 6 month | Segment Expenditure Addition To Long Lived Assets 9 month | Segment Expenditure Addition To Long Lived Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $84.70M 10-Q · filed 2026-07-30 | $161.30M 10-Q · filed 2026-07-30 | $263.20M derived: sum of 3 quarters · filed 2026-07-30 | $343.70M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $76.60M 10-Q · filed 2026-04-30 | $178.50M derived: sum of 2 quarters · filed 2026-04-30 | $259.00M derived: sum of 3 quarters · filed 2026-04-30 | $353.10M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $101.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $182.40M derived: sum of 2 quarters · filed 2026-02-12 | $276.50M derived: sum of 3 quarters · filed 2026-07-30 | $363.50M 10-K · filed 2026-02-12 |
| 2025-09-30 | $80.50M 10-Q · filed 2025-10-30 | $174.60M derived: sum of 2 quarters · filed 2026-07-30 | $261.60M 10-Q · filed 2025-10-30 | $386.20M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $94.10M 10-Q · filed 2026-07-30 | $181.10M 10-Q · filed 2026-07-30 | $305.70M derived: sum of 3 quarters · filed 2026-07-30 | $416.90M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $87.00M 10-Q · filed 2026-04-30 | $211.60M derived: sum of 2 quarters · filed 2026-04-30 | $322.80M derived: sum of 3 quarters · filed 2026-04-30 | $388.90M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $124.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $235.80M derived: sum of 2 quarters · filed 2026-02-12 | $301.90M derived: sum of 3 quarters · filed 2026-02-12 | $358.80M 10-K · filed 2026-02-12 |
| 2024-09-30 | $111.20M 10-Q · filed 2025-10-30 | $177.30M derived: sum of 2 quarters · filed 2025-10-30 | $234.20M 10-Q · filed 2025-10-30 | |
| 2024-06-30 | $66.10M 10-Q · filed 2025-07-30 | $123.00M 10-Q · filed 2025-07-30 | ||
| 2024-03-31 | $56.90M 10-Q · filed 2025-05-01 | |||
| 2023-12-31 | $236.60M 10-K · filed 2026-02-12 | |||
| 2022-12-31 | $364.80M 10-K · filed 2025-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |